near-significantp = 0.009
When a Bonferroni correction was made with statistical significance accepted at the p < 0.006 level, there was a statistically significant superiority in survival distributions for azathioprine over dapsone (χ 2 (1)=11.56; p = 0.001) as well as a near-significant superiority for MMF over dapsone (χ 2 (1)=6.83; p = 0.009) and for rituximab over dapsone (χ 2 (1)=6.20; p = 0.013).